SCHEDULE 13G

CUSIP No.

20678X304

1

Names of Reporting Persons

Sarborg Ltd

2

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 123,595.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 123,595.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

123,595.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

11

Percent of class represented by amount in row (9)

4.0 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: On May 15, 2025, the Issuer effected a 1-for-15 reverse stock split (the "Reverse Split"). The number of shares of Common Stock reported has been adjusted to give effect to the Reverse Split.

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

CDT Equity Inc.

(b)

Address of issuer's principal executive offices:

4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FLORIDA, 34103.

Item 2.

(a)

Name of person filing:

Sarborg Limited, a Cayman Islands company (?Sarborg?).

(b)

Address or principal business office or, if none, residence:

Willow House, Cricket Square, Grand Cayman, Cayman Islands, KY1-1107.

(c)

Citizenship:

Sarborg is a Cayman Islands company.

(d)

Title of class of securities:

Common Stock

(e)

CUSIP No.:

20678X304

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

123,595

(b)

Percent of class:

4.0%, which is based on 3,065,025 shares of common stock, par value $0.0001 per share, of CDT Equity Inc. (formerly known as Conduit Pharmaceuticals Inc., the "Issuer"), issued and outstanding as of August 13, 2025, as independently confirmed by the Issuer.

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

123,595

(ii) Shared power to vote or to direct the vote:

0

(iii) Sole power to dispose or to direct the disposition of:

123,595

(iv) Shared power to dispose or to direct the disposition of:

0

Item 5.

Ownership of 5 Percent or Less of a Class.

Ownership of 5 percent or less of a class

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Sarborg Ltd

Signature:	/s/ Mark Taylor
Name/Title:	Executive Director
Date:	08/18/2025